Beryllium Quantitative, Serum or Plasma
Also known as: BERYLLI SP
Use
This test is used to confirm exposure to beryllium but is not useful for determining the time since exposure or the extent of exposure. For a more reliable indicator of beryllium sensitization and/or chronic beryllium disease (CBD), refer to the Beryllium Lymphocyte Proliferation, Blood (2011052) test.
Special Instructions
Not provided.
Limitations
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration. It is performed by a non-ARUP laboratory, and separate specimens must be submitted when multiple tests are ordered.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
Beryllium
Analyte
LOINC Codes
- 5594-7 - Beryllium SerPl-mCnc
Result Turnaround Time
8-11 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
0.6 mL
Container
Acid Washed Transport Vial
Collection Instructions
Collect specimen in a Royal Blue (no additive) or Royal Blue (EDTA) tube. Separate from cells ASAP or within 2 hours of collection.
Storage Instructions
Refrigerated. Also acceptable: Room temperature or frozen.
Causes for Rejection
Separator tubes.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 2 weeks |
| Refrigerated | 2 weeks |
| Frozen | 2 weeks |
Other tests from different labs that may be relevant